Born from a 2.9 million euro European research project initiated in 2013, BeatHealth places rhythm at the core of its therapeutic approach. The company has developed BeatMove, a patented device that synchronizes music to the user's walking cadence, thereby facilitating movement for individuals with Parkinson's disease and other age-related pathologies.
Supported by the University Innovation Hub (PUI) of Montpellier, BeatHealth has benefited from funding and business creation support programs. The BeatMove device has shown significant clinical benefits, prompting the creation of the start-up to meet patient demand.
The company maintains a strong scientific identity, regularly publishing the clinical benefits of its innovations. A CIFRE thesis, co-supervised by BeatHealth and the Euromov: Digital Health in Motion laboratory, is currently underway to prove the solution's effects on the elderly.
The originality of BeatMove lies in its use of music rather than a metronome, and its adaptive nature: the music adjusts in real-time to the user's walking speed, thereby enhancing the therapeutic benefits.
Recognized with several awards, including the special "Researchers" prize at the HandiTech Trophy 2022, BeatHealth saw France Parkinson take a stake in its capital in early 2026. The company is launching a crowdfunding campaign for large-scale deployment and new development projects, including a LabCom project with the University of Montpellier.
